Cargando…
Perspectives of JAK Inhibitors for Large Vessel Vasculitis
Vasculitis is an inflammation of the blood vessels caused by autoimmunity and/or autoinflammation, and recent advances in research have led to a better understanding of its pathogenesis. Glucocorticoids and cyclophosphamide have long been the standard of care. However, B-cell depletion therapy with...
Autores principales: | Watanabe, Ryu, Hashimoto, Motomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005632/ https://www.ncbi.nlm.nih.gov/pubmed/35432355 http://dx.doi.org/10.3389/fimmu.2022.881705 |
Ejemplares similares
-
Vasculitogenic T Cells in Large Vessel Vasculitis
por: Watanabe, Ryu, et al.
Publicado: (2022) -
Pathogenic role of monocytes/macrophages in large vessel vasculitis
por: Watanabe, Ryu, et al.
Publicado: (2022) -
Cellular Signaling Pathways in Medium and Large Vessel Vasculitis
por: Watanabe, Ryu, et al.
Publicado: (2020) -
Vasculitis associated with VEXAS syndrome: A literature review
por: Watanabe, Ryu, et al.
Publicado: (2022) -
Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors
por: Matsumoto, Kotaro, et al.
Publicado: (2023)